Clinical Trial Update: Bioequivalence Test of Hemay005 Tablets [Phase 1]

View source ↗

Summary

Completed Phase 1 bioequivalence study of Hemay005 tablets for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: COMPLETED